Valiant Mauritius Partners sold 219,000 shares of Zota Health Care for ₹27.18 Cr at ₹1241.00 apiece in a block deal.
An Indian pharmaceutical manufacturer that produces and markets a diverse range of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. The company exports its portfolio across semi-regulated and regulated markets in Asia, Africa, Russia, and Latin America, serving healthcare needs in multiple emerging markets. Zota Health Care operates across multiple therapeutic categories and consumer health segments to cater to varied patient requirements globally.
Mauritius-based investment vehicle of Valiant Capital, a San Francisco hedge fund. Invests in listed Indian equities.
